The global Near-infrared Brain Imaging Systems market size is predicted to grow from US$ 191 million in 2025 to US$ 268 million in 2031; it is expected to grow at a CAGR of 5.8% from 2025 to 2031.

Functional near-infrared spectroscopy (fNIR) is a neroimaging modality that enables continuous, noninvasive, and portable monitoring of changes in blood oxygenation and blood volume related to human brain function. This report counts near-infrared brain imaging equipment systems.

United States market for Near-infrared Brain Imaging Systems is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Near-infrared Brain Imaging Systems is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Near-infrared Brain Imaging Systems is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Near-infrared Brain Imaging Systems players cover Artinis Medical Systems, Nirx, NirScan, Shimadzu, UCL (LUMO), etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

Infinity Market Research newest research report, the “Near-infrared Brain Imaging Systems Industry Forecast” looks at past sales and reviews total world Near-infrared Brain Imaging Systems sales in 2024, providing a comprehensive analysis by region and market sector of projected Near-infrared Brain Imaging Systems sales for 2025 through 2031. With Near-infrared Brain Imaging Systems sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Near-infrared Brain Imaging Systems industry.

This Insight Report provides a comprehensive analysis of the global Near-infrared Brain Imaging Systems landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Near-infrared Brain Imaging Systems portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Near-infrared Brain Imaging Systems market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Near-infrared Brain Imaging Systems and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Near-infrared Brain Imaging Systems.

This report presents a comprehensive overview, market shares, and growth opportunities of Near-infrared Brain Imaging Systems market by product type, application, key players and key regions and countries.

Segmentation by Type:

    Portable
    Desktop

Segmentation by Application:

    Hospitals and Clinics
    Research Laboratories
    Others

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil

    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia

    Europe
        Germany
        France
        UK
        Italy
        Russia

    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

    Artinis Medical Systems
    Nirx
    NirScan
    Shimadzu
    UCL (LUMO)
    Hanix
    OBELAB
    Brite MKII
    BIOPAC Systems Inc